Bryan Jackson Email & Phone Number
@arvinas.com
2 phones found area 814
LinkedIn matched
Who is Bryan Jackson? Overview
A concise factual answer block for searchers comparing this professional profile.
Bryan Jackson is listed as Executive Director, Asset Project Leader at Recursion, a with 846 employees, based in Philadelphia, Pennsylvania, United States. AeroLeads shows a work email signal at arvinas.com, phone signal with area code 814, and a matched LinkedIn profile for Bryan Jackson.
Bryan Jackson previously worked as Early Development Leader at Arvinas and Executive Director, Early Development Leader at Arvinas. Bryan Jackson holds Mba from The Wharton School.
Email format at Recursion
This section adds company-level context without repeating Bryan Jackson's masked contact details.
AeroLeads found 1 current-domain work email signal for Bryan Jackson. Compare company email patterns before reaching out.
About Bryan Jackson
Dynamic leader with 20 years of experience in global R&D, strategic program management, and early-to-mid stage biopharmaceutical drug development. Proven ability to lead cross-functional teams in oncology, immunology, infectious disease, cardiovascular, metabolism and neuroscience disease areas, overseeing comprehensive product development strategies that ensure successful regulatory filings and program execution. Exceptional communicator with a track record of collaborating with executive leadership and stakeholders.Global Team Leadership | Cross-functional Matrixed Leadership | Asset Strategy & Execution | Entrepreneurial | Research & Development | Early & Late Drug Development | Regulatory Strategy | Alliance Relationship Management | Risk Management & Mitigation | Market Awareness & Competitive Analysis
Listed skills include R&D, Chemistry, Technology Transfer, Pharmaceutical Industry, and 41 others.
Bryan Jackson's current company
Company context helps verify the profile and gives searchers a useful next step.
Bryan Jackson work experience
A career timeline built from the work history available for this profile.
Early Development Leader
Executive Director, Early Development Leader
CurrentGlobal cross functional development team leader for neuroscience and oncology development programs leading teams through creation and execution of integrated drug development strategies leveraging novel protein degradation modalities for patients diagnosed with lymphoma, solid tumors, Parkinson's disease and progressive supranuclear palsy.Assets: ARV-393 BCL6 degrader for B-cell lymphomas; ARV-102 LRRK2 degrader for Parkinson’s disease and Progressive Supranuclear Palsy; Undisclosed oncology target
Director, Early Development Leader
Global cross functional development leader for oncology development programs leading teams through creation and execution of integrated drug development strategies leveraging novel adoptive T-cell receptor therapies for patients diagnosed with solid tumor cancers.Assets: MAGE-A4 afami-cel T-cell therapy in combination w/ radiation and anti-PD1 for the treatment of squamous cell carcinomas; partnered undisclosed multi-target T-cell therapies
Project Leader, Cmc
Global CMC team leader for multiple small molecule programs, overseeing the development and commercialization of therapies for oncology, immunology, metabolism, infectious disease and neuroscience from preclinical through clinical and post-launch stages.Developed integrated CMC project plans, including risk management strategies, timelines, and budgets, driving the successful execution of multiple programs across various stages of development.Assets: Ph1-3 development of Orexin-2 agonist for patients with major depressive disorder with insomnia symptoms (Seltorexant); Ph1-2 development of IL-23 pathway therapies for patients with Crohn’s disease and ulcerative colitisPh1 development of BTK inhibitor for patients with hematological malignancies; Ph3 development/ commercialization of EGFR TKI inhibitor for patients with NSCLC (Lazcluze™); Ph3 development/ commercialization of chemotherapy for patients with sarcoma or ovarian cancer (Yondelis®); life-cycle management of Factor X inhibitor to prevent blood clotting (Xarelto®)
Project Manager And Alliance Manager
Directed technical projects encompassing transfer, process development, commercial manufacturing, quality/regulatory oversight, and product lifecycle management. Led cross-functional teams in all facets of CMC and regulatory drug development and manufacturing. Alliance Manager and primary point of contact for biotech/pharmaceutical partner companies, facilitating product development across all phases of clinical trials and commercial launches. Assets: Xyrem® for the treatment of cataplexy and excessive daytime sleepiness for patients with narcolepsy; Auryxia® treating hyperphosphatemia and iron deficiency anemia in patients with CKD
Operations Manager
Team Leader / Senior Scientist
Research Investigator
Postdoctoral Research Fellow
Research Assistant
Areas of Expertise: High pressure and super-critical Chemistry, Solid State Chemistry & Crystallization, Advanced material characterization methodsDissertation: High pressure growth of silicon wires inside microstructured optical fibers
Colleagues at Recursion
Other employees you can reach at recursionpharma.com. View company contacts for 846 employees →
Danielle Langley
Colleague at RecursionGreater Oxford Area, United Kingdom
View →
KR
Kelly Reihl
Colleague at RecursionSalt Lake City, Utah, United States
View →
JJ
Joe Janiszewski
Colleague at RecursionSalt Lake City, Utah, United States
View →
MN
Meg Nilsson
Colleague at RecursionBountiful, Utah, United States
View →
RC
Ross Collins
Colleague at RecursionAbingdon-On-Thames, England, United Kingdom
View →
LM
Lizzie Marroquin
Colleague at RecursionSalt Lake City, Utah, United States
View →
RG
Richard Gildea
Colleague at RecursionGreater Oxford Area, United Kingdom
View →
JG
Jonathan Golightly, Cep
Colleague at RecursionOrem, Utah, United States
View →
ET
Emilia Temple-Wheeler
Colleague at RecursionSalt Lake City, Utah, United States
View →
JS
Jordan Sorokin, Phd
Colleague at RecursionFort Collins, Colorado, United States
View →
Bryan Jackson education
Mba
Ph.D, Materials Science
Bachelor Of Science - Bs, Chemistry
Frequently asked questions about Bryan Jackson
Quick answers generated from the profile data available on this page.
What company does Bryan Jackson work for?
Bryan Jackson works for Recursion.
What is Bryan Jackson's role at Recursion?
Bryan Jackson is listed as Executive Director, Asset Project Leader at Recursion.
What is Bryan Jackson's email address?
AeroLeads has found 1 work email signal at @arvinas.com for Bryan Jackson at Recursion.
What is Bryan Jackson's phone number?
AeroLeads has found 2 phone signal(s) with area code 814 for Bryan Jackson at Recursion.
Where is Bryan Jackson based?
Bryan Jackson is based in Philadelphia, Pennsylvania, United States while working with Recursion.
What companies has Bryan Jackson worked for?
Bryan Jackson has worked for Recursion, Arvinas, Adaptimmune, Johnson & Johnson, and Siegfried Llc.
Who are Bryan Jackson's colleagues at Recursion?
Bryan Jackson's colleagues at Recursion include Danielle Langley, Kelly Reihl, Joe Janiszewski, Meg Nilsson, and Ross Collins.
How can I contact Bryan Jackson?
You can use AeroLeads to view verified contact signals for Bryan Jackson at Recursion, including work email, phone, and LinkedIn data when available.
What schools did Bryan Jackson attend?
Bryan Jackson holds Mba from The Wharton School.
What skills is Bryan Jackson known for?
Bryan Jackson is listed with skills including R&D, Chemistry, Technology Transfer, Pharmaceutical Industry, Fda, Validation, Project Management, and Gmp.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial